Statement on FDA’s Proposed Oversight of Laboratory-Developed Tests

Posted on by admin

A statement on the announcement by the Food and Drug Administration (FDA) that it plans to take steps to improve the oversight of laboratory-developed tests (LDTs).
SOURCE: NIH Director’s Page – Read entire story here.

Related posts:

  1. NIH featured on C-SPAN’s Washington Journal Watch NIH leadership on C-SPAN's Washington Journal discussing important, groundbreaking research for multiple diseases and conditions. ...
  2. Phaedra Corso named UGA Foundation Professor of Human Health Phaedra Corso, Ph.D., MPA, professor of health policy and management in the University of Georgia College of Public Health, has been named the inaugural UGA Foundation Professor of Human Health.  The professorship was approved by the Board of Regents at its September 2013 meeting and became effective Jan. 1. read more ...
  3. Comparative Effectiveness And Cost-Effectiveness Analyses Frequently Agree On Value [Value & Quality] The Patient-Centered Outcomes Research Institute, known as PCORI, was established by Congress as part of the Affordable Care Act (ACA) to promote evidence-based treatment. Provisions of the ACA prohibit the use of a cost-effectiveness analysis threshold and quality-adjusted life-years (QALYs) in PCORI comparative effectiveness studies, which has been understood as a prohibition on support for PCORI’s conducting conventional cost-effectiveness analyses. This constraint complicates evidence-based choices where incremental improvements in outcomes are achieved at increased costs of care. How frequently this limitation inhibits efficient cost containment, also a goal of the ACA, depends on how often more effective treatment is not...
  4. Fixing problems with cell lines Dr. Collins and NIGMS Director Dr. Jon Lorsch author an article in Science Magazine addressing cell line misidentification in research and suggesting best practices for authentication and verification. Science Magazine. December 19, 2014. ...
  5. Appointment of Adrienne A. Hallett as the Associate Director for Legislative Policy and Analysis, NIH Ms. Hallett will join NIH on May 4, 2015. ...

Related Posts